Clinical trial

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

NCT00329095

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention travoprost, latanoprost, or bimatoprost Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Additional ocular hypotensive medication Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-12-01

PhasePHASE4

Conditions

Glaucomaverified · MONDO: glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

travoprost, latanoprost, or bimatoprostDRUG

Additional ocular hypotensive medicationDRUG

Sponsors & collaborators

Robin, Alan L., M.D.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00329095 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.